Literature DB >> 15290096

Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage.

Dashnamoorthy Ravi1, Kumuda C Das.   

Abstract

Anthracyclines such as doxorubicin and daunomycin undergo bioreductive activation by redox-cycling, and this is associated with generation of reactive oxygen species. Toxicity of anthracyclines is attributed to DNA intercalation by an anthracycline semiquinone radical that is generated via redox-cycling. Flavoprotein enzymes catalyze the bioreductive activation of anthracyclines. Thioredoxin reductase (TR), which is also a flavoprotein enzyme, participates in bioreductive activation of anthracyclines. In the present study we showed that addition of E. coli thioredoxin (Trx) enhances the rate of superoxide production by E. coli TR in the presence of anthracyclines. The superoxide generated in this redox-cycling process induced DNA damage as determined by an in vitro plasmid DNA damage assay. In addition, Trx-SH enhanced the activity of cyto-chrome P450 reductase and the redox-cycling of anthracyclines independently of NADPH. Furthermore,when A549 cells were incubated with E. coli Trx followed by doxorubicin treatment, increased levels of ROS generation were observed. Taken together, these results show a novel property of the Trx system in bioreductive activation of anthracyclines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290096     DOI: 10.1007/s00280-004-0833-y

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

Review 1.  Role of Bcl-2 family proteins and caspases in the regulation of apoptosis.

Authors:  Mohammad Shamsul Ola; Mohd Nawaz; Haseeb Ahsan
Journal:  Mol Cell Biochem       Date:  2011-01-06       Impact factor: 3.396

2.  Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells.

Authors:  Nnenna Adimora Finn; Melissa Lambeth Kemp
Journal:  Mol Biosyst       Date:  2011-12-01

3.  Thioredoxin-deficient mice, a novel phenotype sensitive to ambient air and hypersensitive to hyperoxia-induced lung injury.

Authors:  Kumuda C Das
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-24       Impact factor: 5.464

4.  Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells.

Authors:  Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Kumuda C Das
Journal:  J Biol Chem       Date:  2015-05-31       Impact factor: 5.157

Review 5.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 6.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

7.  Characterization of a microsphere formulation containing glucose oxidase and its in vivo efficacy in a murine solid tumor model.

Authors:  Qun Liu; Andrew Michael Rauth; Jiang Liu; Karlo Babakhanian; Xinyue Wang; Reina Bendayan; Xiao Yu Wu
Journal:  Pharm Res       Date:  2009-08-15       Impact factor: 4.200

8.  14-3-3 σ expression effects G2/M response to oxygen and correlates with ovarian cancer metastasis.

Authors:  Dashnamoorthy Ravi; Yidong Chen; Bijal Karia; Adam Brown; Ting Ting Gu; Jie Li; Mark S Carey; Bryan T Hennessy; Alexander J R Bishop
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

9.  JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1.

Authors:  Kornelia Edes; Pamela Cassidy; Paul J Shami; Philip J Moos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis.

Authors:  Kumuda C Das; Harish Muniyappa; Venkatesh Kundumani-Sridharan; Jaganathan Subramani
Journal:  Cardiovasc Toxicol       Date:  2020-09-03       Impact factor: 3.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.